A DEA order to show cause is a proposal to deny a federal registration application, not a final denial. Citing unnamed industry sources, Marijuana Moment reported on November 11, 2026 that DEA has sent these orders to at least some medical marijuana businesses in California, Delaware, the District of Columbia, Illinois, North Dakota and Oregon. The orders relate to the April 28, 2026 rule that placed state-licensed medical marijuana in Schedule III, so that is where to start reading.
Quick facts as of November 12, 2026
| Item | Detail |
|---|---|
| Latest reporting | Marijuana Moment, November 11, 2026, citing unnamed industry sources who reviewed the orders |
| Orders to show cause | Sent to at least some businesses in California, Delaware, the District of Columbia, Illinois, North Dakota and Oregon |
| Rejections | DEA has rejected applications for federal registration in at least six states and Washington, D.C., per Marijuana Moment |
| Minnesota | DEA rejected Minnesota applicants in late October 2026, citing certain provisions of that state’s laws, per Marijuana Moment |
| Schedule III rule | Effective April 28, 2026; covers FDA-approved products and marijuana subject to a state medical marijuana license |
| Non-medical marijuana | A DEA judge is considering a proposal to move it to Schedule III, per Marijuana Moment |
What is a DEA order to show cause?
DEA uses the term for a proposal to deny an application. In a DEA Federal Register notice for another applicant, an order to show cause is described as one that “proposed the denial” of an application. Marijuana Moment calls the actions in this story rejections, and says the orders reached “at least some businesses” in the named states.
Which states are named?
Marijuana Moment says orders to show cause went to businesses in California, Delaware, D.C., Illinois, North Dakota and Oregon, and that the documents differ by state while sharing common themes. Minnesota is a separate case. In late October 2026, DEA approved more than 900 applicants across seven states and rejected those in Minnesota, according to the same outlet.
What reasons do the orders give?
Marijuana Moment attributes these points to unnamed industry sources who reviewed the orders, some of which were shared with the outlet.
| Reason | What the order text says, as reported |
|---|---|
| Adult-use sales | States that let businesses sell non-medical (adult-use) marijuana are said to break the Controlled Substances Act’s “closed system” for medical access to scheduled drugs, and U.S. treaty obligations. |
| Dispensing without a written certification | The California order says DEA cannot register a medical marijuana dispensary under California’s state regime, because the state allows dispensing without a written certification. It argues this conflicts with the Single Convention’s requirement for medical prescriptions, and cites a state form marked as not mandatory. |
| Patients without a written recommendation | Some orders single out state laws that let certain patients obtain medical cannabis “without a doctor’s written recommendation.” The California order notes that patients applying for a medical marijuana ID card do not have to obtain or provide a physician’s recommendation. |
| Dual medical and recreational licensing | The Illinois order says the state’s dual licensing lacks “robust protections” against diversion, because non-medical use stays prohibited under federal law. It says DEA cannot give any Illinois applicant access to the federal closed system. |
| Veterans’ records | The Illinois order cites a law that lets veterans qualify with one year of VA medical records instead of a doctor’s certification. Marijuana Moment says the Minnesota order describes the same provision. |
| Washington, D.C. | MJBizDaily has reported that a D.C. order cites the city’s self-certification policy for patients. |
What does the Schedule III rule do for state medical licensees?
The Federal Register final rule was published April 28, 2026 as AG Order No. 6754-2026 and took effect the same day. It places marijuana, marijuana extract and naturally derived delta-9-THC tied to a state medical marijuana license in Schedule III, along with FDA-approved products containing marijuana.
The rule also opens an expedited registration path under 21 CFR 1301.13(k). It says DEA must register an applicant unless it finds that registration would be inconsistent with the public interest. A state regime with strong diversion protections, recordkeeping and reporting rules, and safety and inspection measures generally will not be found inconsistent, as long as registration is consistent with the Single Convention.
For dispensing, the rule’s written certification standard in 1301.13(k)(5) says a state certification works if it is dated and signed the day it is issued, shows the patient’s full name and address, and names the signing practitioner along with that practitioner’s address and state license number. This is the provision DEA cites in the California order.
The Marijuana Herald’s April 2026 rule summary reports that dispensaries transferring medical marijuana to patients must register with DEA as practitioners, while manufacturers and distributors register under their own categories. It also reports that adult-use marijuana stays outside the new rule.
Is there a rescheduling of the marijuana ban in 2026?
Partly. The April 28 rule covers medical marijuana and FDA-approved products. Marijuana Moment reports that a DEA judge is weighing a proposal to move non-medical marijuana to Schedule III, after a hearing that included testimony and briefs, and that it is unclear when the judge will send a recommendation to the agency’s administrator. The Marijuana Herald’s April 2026 report had listed a June 29 hearing on rescheduling all marijuana. You can follow the wider picture in our marijuana rescheduling page.
Is Schedule I or Schedule III a worse drug?
Schedule III is the lower category. The Ohio council’s summary of the order explains that marijuana had been placed in Schedule I on the finding of no accepted medical use and high abuse potential. The Marijuana Herald reports that the rule’s background cites a 2023 HHS recommendation, which found that marijuana has lower abuse potential than Schedule I and II substances. Schedules set federal handling rules for the substance, and that is the question the rule answers for licensed medical businesses.
What are the key dates?
Under the DEA timely applicant guidance, state licensees that submitted a complete application plus fee in the window below are Timely Applicants. The guidance also sets the supply-chain date shown in the table. For background on the timing, see our marijuana Schedule III timeline.
| Date | What happens |
|---|---|
| April 28, 2026 | The Schedule III rule is published in the Federal Register and takes effect. |
| April 28 to June 26, 2026 | State licensees that submit a complete application plus fee are Timely Applicants, per DEA’s timely applicant guidance. |
| June 29, 2026 | Scheduled in April 2026 for a DEA hearing on broader rescheduling, per The Marijuana Herald. Marijuana Moment’s November 11 report says the hearing has since taken place, with testimony and briefs. |
| Late October 2026 | DEA approves more than 900 applicants across seven states and rejects Minnesota applicants, per Marijuana Moment. |
| November 11, 2026 | Marijuana Moment reports orders to show cause in California, Delaware, D.C., Illinois, North Dakota and Oregon. |
| November 29, 2026 | Timely Applicants are expected to have compliant supply chains in place, per DEA’s timely applicant guidance. |
Who does this affect?
- State-licensed medical marijuana businesses seeking DEA registration as manufacturers, distributors or dispensers.
- Timely Applicants. These are state licensees that submitted a complete application plus fee between April 28 and June 26, 2026. They may dispense, manufacture or distribute under their state license while the application is pending. Applicants who withdrew, were denied by a Final Order, or lack a state license are excluded.
- Businesses that buy from or sell to them. DEA’s guidance says that during that window, Timely Applicants and registrants cannot lawfully handle Schedule III medical marijuana business with companies that never applied.
- Patients. The reporting covers DEA registration and federal protection for these businesses. For how the rule relates to a medical card, read our DEA registration and your medical marijuana card guide.
Common mix-ups
- Order to show cause vs. final denial. An order to show cause proposes a denial. Marijuana Moment calls these orders rejections.
- Medical vs. adult-use. The Schedule III rule covers state medical licenses and FDA-approved products. Adult-use marijuana is outside it.
- Rule vs. guidance. The April 28 rule is a final rule. DEA’s timely applicant guidance says it does not carry the force of law.
- Rescheduling vs. registration. The Schedule III placement comes from the rule. DEA registration is a separate application that the rule opens to state licensees.
Before you act: questions that settle your next step
- Did your business submit a complete application and fee between April 28 and June 26, 2026? That decides whether you are a Timely Applicant.
- Has your business received an order to show cause, a final order, or neither? Keep every DEA letter with its date.
- Do your supply partners have DEA confirmations, document control numbers and active state licenses? Keep records of each check.
- If you are a Timely Applicant, is your supply chain set up before November 29, 2026?
- Ask a cannabis regulatory attorney what an order to show cause means for your license, your products and your next filing.
This page does not give legal advice.
By HealthDataConsortium.org Research Team
This article is for general information purposes only and does not constitute medical advice. Consult your doctor or qualified healthcare provider before making changes to your health routine.
